VCs Invest $23M In Roche Holding Spinout Afferent Pharmaceuticals

News | 12. 16. 2009

Afferent Pharmaceuticals

Venture firms are investing $23 million to spin out a start-up from Roche Holding Ltd. that plans to attack chronic pain in a new way.